Synthes shows solid 2009 figures but is cautious

Swiss medical device maker Synthes reports a 12 per cent increase in net profit for 2009 but is careful about its short-term outlook.

This content was published on February 17, 2010 - 10:56

The company, which makes implants and biomaterials used in surgery on the skeleton, says income increased to $824 million (SFr879 million) on sales of 3.4 billion (+6.3 per cent).

Synthes said on Wednesday that the start of 2010 had been encouraging after a disappointing fourth quarter.

“We are not satisfied with the fourth quarter top line (sales) growth; however, we are encouraged by the higher growth rate in early 2010,” commented Synthes chief executive Michel Orsinger.

“My personal focus this year is on keeping the innovation cycle high and on increasing the effectiveness of our sales force.”

A company statement said Synthese did not expect the “challenging market environment to change significantly in the short term”. and agencies

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.